Intrinsic Value of S&P & Nasdaq Contact Us

Insulet Corporation PODD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
74/100
4/7 Pass
SharesGrow Intrinsic Value
$321.45
+59.5%
Analyst Price Target
$357.25
+77.3%

Insulet Corporation (PODD) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Acton, MA, United States. The current CEO is Ashley A. McEvoy.

PODD has IPO date of 2007-05-15, 5,400 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $14.18B.

About Insulet Corporation

Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's flagship product is the Omnipod System, a tubeless, self-adhesive disposable insulin pump worn on the body for up to three days, controlled wirelessly by a handheld personal diabetes manager. Insulet distributes its products through independent distributors, pharmacy channels, and direct sales across the United States, Canada, Europe, the Middle East, and Australia. Founded in 2000 and headquartered in Acton, Massachusetts, the company serves a global market of insulin-dependent diabetes patients seeking convenient, modern insulin delivery solutions.

📍 100 Nagog Park, Acton, MA 01720 📞 978 600 7000
Company Details
SectorHealthcare
IndustryMedical - Devices
CountryUnited States
ExchangeNASDAQ Global Select
CurrencyUSD
IPO Date2007-05-15
CEOAshley A. McEvoy
Employees5,400
Trading Info
Current Price$201.49
Market Cap$14.18B
52-Week Range202.44-354.88
Beta1.47
ETFNo
ADRNo
CUSIP45784P101
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message